HK1101327A1 - Amine salt of carbostyril derivative - Google Patents

Amine salt of carbostyril derivative

Info

Publication number
HK1101327A1
HK1101327A1 HK07109247.5A HK07109247A HK1101327A1 HK 1101327 A1 HK1101327 A1 HK 1101327A1 HK 07109247 A HK07109247 A HK 07109247A HK 1101327 A1 HK1101327 A1 HK 1101327A1
Authority
HK
Hong Kong
Prior art keywords
amine salt
carbostyril derivative
carbostyril
derivative
amine
Prior art date
Application number
HK07109247.5A
Other languages
English (en)
Inventor
Yoshihiro Nishioka
Shinji Aki
Shigekazu Fujita
Yoshinao Onishi
Shun-Ichiro Sumida
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1101327A1 publication Critical patent/HK1101327A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07109247.5A 2004-01-21 2007-08-24 Amine salt of carbostyril derivative HK1101327A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004013402 2004-01-21
PCT/JP2005/001034 WO2005070892A1 (en) 2004-01-21 2005-01-20 Amine salt of carbostyril derivative

Publications (1)

Publication Number Publication Date
HK1101327A1 true HK1101327A1 (en) 2007-10-12

Family

ID=34805383

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07109247.5A HK1101327A1 (en) 2004-01-21 2007-08-24 Amine salt of carbostyril derivative
HK11102692.4A HK1148527A1 (en) 2004-01-21 2011-03-17 Amine salt of carbostyril derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11102692.4A HK1148527A1 (en) 2004-01-21 2011-03-17 Amine salt of carbostyril derivative

Country Status (23)

Country Link
US (2) US7732611B2 (zh)
EP (2) EP1706383B1 (zh)
JP (1) JP4516962B2 (zh)
KR (1) KR100844762B1 (zh)
CN (1) CN1934086B (zh)
AR (1) AR047438A1 (zh)
AT (1) ATE549318T1 (zh)
AU (1) AU2005206430B2 (zh)
BR (1) BRPI0506982A (zh)
CA (1) CA2553231C (zh)
CY (2) CY1112723T1 (zh)
DK (2) DK2253619T3 (zh)
ES (2) ES2382133T3 (zh)
HK (2) HK1101327A1 (zh)
HU (1) HUE027990T2 (zh)
MY (1) MY148416A (zh)
PL (2) PL1706383T3 (zh)
PT (2) PT2253619E (zh)
RU (1) RU2372336C2 (zh)
SG (1) SG149854A1 (zh)
SI (2) SI1706383T1 (zh)
TW (1) TWI340650B (zh)
WO (1) WO2005070892A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187197B1 (en) * 1998-10-28 2001-02-13 Marvin Haddock Multi-stage engine coolant recycling process
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
CN101778626B (zh) * 2007-08-10 2014-05-07 大塚制药株式会社 含有瑞巴派特的药物组合物
US9486418B2 (en) 2008-04-08 2016-11-08 Dynamis Pharmaceuticals, Inc. Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
CN102099056B (zh) * 2008-06-19 2014-10-01 大塚制药株式会社 药物组合物
US9248196B2 (en) 2011-02-25 2016-02-02 Nuformix Limited Rebamipide complexes and cocrystals

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS517614Y2 (zh) * 1971-02-12 1976-03-01
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JPS597168A (ja) 1982-07-05 1984-01-14 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
DK0543018T3 (da) * 1991-06-07 1996-02-05 Otsuka Pharma Co Ltd Antidiabetikum
TW227558B (zh) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
KR100191191B1 (ko) * 1993-10-21 1999-06-15 오쓰까 아끼히꼬 인터루킨-8합성억제의 카르보스티릴 유도체
AU8003194A (en) 1993-11-05 1995-05-23 Otsuka Pharmaceutical Co., Ltd. Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers
JP3621463B2 (ja) 1995-04-26 2005-02-16 大塚製薬株式会社 カルボスチリル誘導体ビスマス塩
AR004214A1 (es) 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
GB9613455D0 (en) 1996-06-27 1996-08-28 Aston Molecules Ltd Analogues or derivatives of quercetin
CA2478599A1 (en) 2002-03-11 2003-09-18 Novartis Ag Salts of nateglinide
KR20040104020A (ko) 2003-06-02 2004-12-10 진양제약주식회사 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
JP4719917B2 (ja) 2007-03-30 2011-07-06 国立大学法人 岡山大学 アズキ加工食品のアズキ原料品種判定方法

Also Published As

Publication number Publication date
CN1934086A (zh) 2007-03-21
BRPI0506982A (pt) 2007-07-03
SI1706383T1 (sl) 2015-09-30
CN1934086B (zh) 2013-01-02
DK2253619T3 (da) 2012-04-16
EP2253619B1 (en) 2012-03-14
HK1148527A1 (en) 2011-09-09
JP2007514641A (ja) 2007-06-07
US8222276B2 (en) 2012-07-17
EP1706383A1 (en) 2006-10-04
AU2005206430B2 (en) 2008-12-11
CY1116773T1 (el) 2017-03-15
SG149854A1 (en) 2009-02-27
CA2553231A1 (en) 2005-08-04
PL2253619T3 (pl) 2012-08-31
EP2253619A1 (en) 2010-11-24
ATE549318T1 (de) 2012-03-15
MY148416A (en) 2013-04-30
SI2253619T1 (sl) 2012-04-30
ES2382133T3 (es) 2012-06-05
HUE027990T2 (en) 2016-11-28
CA2553231C (en) 2012-03-13
KR100844762B1 (ko) 2008-07-07
TW200529873A (en) 2005-09-16
US20100210684A1 (en) 2010-08-19
AU2005206430A1 (en) 2005-08-04
TWI340650B (en) 2011-04-21
JP4516962B2 (ja) 2010-08-04
KR20060123566A (ko) 2006-12-01
RU2372336C2 (ru) 2009-11-10
WO2005070892A1 (en) 2005-08-04
US20070155787A1 (en) 2007-07-05
ES2544327T3 (es) 2015-08-28
PT1706383E (pt) 2015-10-15
PT2253619E (pt) 2012-03-29
DK1706383T3 (en) 2015-08-03
RU2006129945A (ru) 2008-02-27
EP1706383B1 (en) 2015-07-22
AR047438A1 (es) 2006-01-18
US7732611B2 (en) 2010-06-08
PL1706383T3 (pl) 2015-12-31
CY1112723T1 (el) 2016-02-10

Similar Documents

Publication Publication Date Title
HK1124233A1 (en) Quinoline derivatives as antibacterical agents
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
ZA200610593B (en) Diphenylimidazopyrimidine and -imidazole amines as inhibitors of ß-secretase
IL208963A0 (en) Substituted quinoline compounds
IL195346A0 (en) Novel heterocyclic compound or salt thereof and intermediate thereof
HK1105592A1 (en) Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors
HK1107348A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
ZA200702333B (en) Cyclic amine derivative or salt thereof
IL181630A0 (en) Carbostyril compound
IL193422A0 (en) Amide derivative or salt thereof
AP2008004444A0 (en) New anti-malaria derivatives of 4-aminoquinoline
IL185470A0 (en) Novel salt of quinuclidine derivative
HK1148527A1 (en) Amine salt of carbostyril derivative
IL192954A0 (en) Salt of cd 80 antagonist
EP1632476A4 (en) ACIDIC ACID SALT OF A CARBAZUCKERAMINE DERIVATIVE
ZA200605575B (en) Substituted quinoline compounds
EP1878719A4 (en) HYDROXYNOREPHEDRINE DERIVATIVE HYDROCHLORIDE POLYMORPH CRYSTAL
ZA200706292B (en) Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
GB0428061D0 (en) Novel Quinoline Compounds
HU0500461D0 (en) Pyperazinyl derivatives of alkyl-oxindoles
PL381715A1 (pl) Nowe pochodne piperazynowe dialkilooksindoli
HU0500462D0 (en) Pyridinyl derivatives of alkyl-oxindoles

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170120